Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
5.42
+0.11 (2.07%)
At close: Dec 5, 2025, 4:00 PM EST
5.38
-0.04 (-0.74%)
After-hours: Dec 5, 2025, 4:04 PM EST
Bolt Biotherapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Net Income | -42.68 | -63.12 | -69.2 | -88.1 | -98.59 | -60.73 | |
| Depreciation & Amortization | 1.46 | 1.78 | 1.85 | 1.67 | 1.19 | 0.61 | |
| Loss (Gain) From Sale of Assets | -0.29 | -0.07 | - | - | 0.11 | - | |
| Asset Writedown & Restructuring Costs | 1.47 | 1.47 | - | - | - | - | |
| Loss (Gain) From Sale of Investments | -0.82 | -2.62 | -4.49 | 0.18 | 2.65 | 0.03 | |
| Stock-Based Compensation | 2.92 | 7.41 | 9.22 | 9.58 | 8.5 | 1.42 | |
| Other Operating Activities | 1.81 | 2.3 | 2.95 | 3.23 | 8.56 | 13.64 | |
| Change in Accounts Payable | -7.93 | -4.88 | -3.41 | 2.77 | 6.68 | 2.88 | |
| Change in Unearned Revenue | -1.97 | -4.67 | -3.61 | -2.16 | 15.57 | -0.07 | |
| Change in Other Net Operating Assets | -1.1 | 1.12 | -2.85 | -3.66 | -1.74 | -5.1 | |
| Operating Cash Flow | -47.12 | -61.29 | -69.53 | -76.5 | -57.07 | -47.31 | |
| Capital Expenditures | -0.07 | -0.04 | -0.21 | -1.95 | -2.34 | -3.26 | |
| Sale of Property, Plant & Equipment | 0.96 | 0.15 | - | - | - | - | |
| Investment in Securities | 54.57 | 57.47 | 71.24 | 59.82 | -229.86 | -17.33 | |
| Investing Cash Flow | 55.46 | 57.58 | 71.04 | 57.86 | -232.2 | -20.59 | |
| Issuance of Common Stock | 0.04 | 0.11 | 0.25 | 0.5 | 259.21 | 0.29 | |
| Other Financing Activities | - | - | - | - | - | -1.97 | |
| Financing Cash Flow | 0.04 | 0.11 | 0.25 | 0.5 | 311.11 | 39.6 | |
| Net Cash Flow | 8.38 | -3.61 | 1.77 | -18.14 | 21.84 | -28.3 | |
| Free Cash Flow | -47.2 | -61.33 | -69.73 | -78.46 | -59.4 | -50.57 | |
| Free Cash Flow Margin | -908.49% | -797.53% | -885.36% | -1369.47% | -4714.60% | -21891.78% | |
| Free Cash Flow Per Share | -24.62 | -32.12 | -36.88 | -42.00 | -35.79 | -481.09 | |
| Levered Free Cash Flow | -31.96 | -37.54 | -39.47 | -46.18 | -41.99 | -29.22 | |
| Unlevered Free Cash Flow | -31.96 | -37.54 | -39.47 | -46.18 | -41.99 | -29.22 | |
| Change in Working Capital | -11 | -8.44 | -9.86 | -3.06 | 20.51 | -2.28 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.